Your browser doesn't support javascript.
loading
Effects of combination therapy with vildagliptin and valsartan in a mouse model of type 2 diabetes.
Miyagawa, Katsutoshi; Kondo, Tatsuya; Goto, Rieko; Matsuyama, Rina; Ono, Kaoru; Kitano, Sayaka; Kawasaki, Shuji; Igata, Motoyuki; Kawashima, Junji; Matsumura, Takeshi; Motoshima, Hiroyuki; Araki, Eiichi.
Affiliation
  • Araki E; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Chuo Ward, Kumamoto 860-8556, Japan. earaki@gpo.kumamoto-u.ac.jp.
Cardiovasc Diabetol ; 12: 160, 2013 Nov 04.
Article in En | MEDLINE | ID: mdl-24188631
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyrrolidines / Tetrazoles / Valine / Blood Glucose / Adamantane / Angiotensin II Type 1 Receptor Blockers / Diabetes Mellitus, Experimental / Diabetes Mellitus, Type 2 / Insulin-Secreting Cells / Dipeptidyl-Peptidase IV Inhibitors Type of study: Prognostic_studies Limits: Animals Language: En Year: 2013 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyrrolidines / Tetrazoles / Valine / Blood Glucose / Adamantane / Angiotensin II Type 1 Receptor Blockers / Diabetes Mellitus, Experimental / Diabetes Mellitus, Type 2 / Insulin-Secreting Cells / Dipeptidyl-Peptidase IV Inhibitors Type of study: Prognostic_studies Limits: Animals Language: En Year: 2013 Type: Article